ID
34097
Descrizione
Study ID: 101682 Clinical Study ID: B2E101682 Study Title: A randomised, double-blind, placebo-controlled, parallel group study to examine the safety, tolerability, and pharmacokinetics of repeat inhaled doses of GSK159797 in healthy subjects. Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: milveterol Trade Name: milveterol Study Indication: Pulmonary Disease, Chronic Obstructive
Keywords
versioni (1)
- 14/01/19 14/01/19 -
Titolare del copyright
GlaxoSmithKline
Caricato su
14 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Safety, tolerability and pharmacokinetics of repeat inhaled doses of milveterol in healthy subjects (Study ID: 101682)
Vital signs
- StudyEvent: ODM
Descrizione
Vital signs
Alias
- UMLS CUI-1
- C0518766
Descrizione
The field Row number is not to be filled in for "mean pre-dose".
Tipo di dati
integer
Alias
- UMLS CUI [1]
- C2348184
Descrizione
The field Date is not to be filled in for "mean pre-dose".
Tipo di dati
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0518766
Descrizione
Time relative to dosing. The row numbers denote the time values under "planned relative time". Session 1: Three measurements for screening (at least 5 minutes apart). Session 2, day 1: Three measurements for "pre-dose" (at least 5 minutes apart), the mean value recorded pre-dose will be classed as baseline. Then measurements at 20mins, 40mins, 1hr, 2hrs, 3hrs, 4hrs, 6hrs, 8hrs, 10hrs, 12hrs, 16hrs, 24hrs. Session 2, day 3,5,8,10,12: One measurement for "pre-dose", remaining measurements as at day 1. Session 2, day 7: One measurement at "pre-dose". Session 2, day 14: one measurement at 24hrs. Session 3: One measurement for Follow-up. Measurements at 24hrs are performed immediately prior to dosing on the following day. Planned relative time "unscheduled" can be filled in at each session and each day if neccessary.
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0518766
Descrizione
The field Actual time is not to be filled in for "mean pre-dose".
Tipo di dati
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0518766
Descrizione
measurements will be made with the subject in a supine position having rested in this position for at least 10 minutes before each reading.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1,1]
- C0871470
- UMLS CUI [1,2]
- C0518766
Descrizione
measurements will be made with the subject in a supine position having rested in this position for at least 10 minutes before each reading.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1,1]
- C0428883
- UMLS CUI [1,2]
- C0518766
Descrizione
measurements will be made with the subject in a supine position having rested in this position for at least 10 minutes before each reading.
Tipo di dati
integer
Unità di misura
- beats/min
Alias
- UMLS CUI [1,1]
- C0018810
- UMLS CUI [1,2]
- C0518766
Similar models
Vital signs
- StudyEvent: ODM
C0518766 (UMLS CUI [1,2])
C0518766 (UMLS CUI [1,2])
C0518766 (UMLS CUI [1,2])
C0518766 (UMLS CUI [1,2])
C0518766 (UMLS CUI [1,2])
C0518766 (UMLS CUI [1,2])